Skip to main content
SpringerLink
Log in

Costs of HCV greater without antiviral therapy

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Perrone V, et al. Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting. ClinicoEconomics and Outcomes Research 2016: 591-597, No. 8, 14 Oct 2016. Available from: URL: https://dx.doi.org/10.2147/CEOR.S108288

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Costs of HCV greater without antiviral therapy. PharmacoEcon Outcomes News 765, 11 (2016). https://doi.org/10.1007/s40274-016-3496-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3496-0

Search

Navigation